DVLA Stock Overview
Engages in the manufacture and trading of pharmaceutical products and cosmetics in Indonesia. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
PT Darya-Varia Laboratoria Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp1,630.00 |
| 52 Week High | Rp1,850.00 |
| 52 Week Low | Rp1,375.00 |
| Beta | -0.096 |
| 11 Month Change | -4.68% |
| 3 Month Change | -1.81% |
| 1 Year Change | -3.26% |
| 33 Year Change | -42.40% |
| 5 Year Change | -26.91% |
| Change since IPO | 91.76% |
Recent News & Updates
Recent updates
Shareholder Returns
| DVLA | ID Pharmaceuticals | ID Market | |
|---|---|---|---|
| 7D | -3.0% | -2.4% | -2.2% |
| 1Y | -3.3% | -9.4% | 9.3% |
Return vs Industry: DVLA exceeded the ID Pharmaceuticals industry which returned -10.1% over the past year.
Return vs Market: DVLA underperformed the ID Market which returned 8.2% over the past year.
Price Volatility
| DVLA volatility | |
|---|---|
| DVLA Average Weekly Movement | 2.7% |
| Pharmaceuticals Industry Average Movement | 3.7% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in ID Market | 12.6% |
| 10% least volatile stocks in ID Market | 2.4% |
Stable Share Price: DVLA has not had significant price volatility in the past 3 months compared to the ID market.
Volatility Over Time: DVLA's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1976 | 1,266 | n/a | www.darya-varia.com |
PT Darya-Varia Laboratoria Tbk engages in the manufacture and trading of pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company provides prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women healthcare, antiparasit, vitamin and food supplements, anti fungal, plastic surgery, general surgery, burn, trauma wound, aesthetic medicine, somatik, ear healthcare, and central nerve systems.
PT Darya-Varia Laboratoria Tbk Fundamentals Summary
| DVLA fundamental statistics | |
|---|---|
| Market cap | Rp1.83t |
| Earnings (TTM) | Rp193.91b |
| Revenue (TTM) | Rp2.13t |
9.4x
P/E Ratio0.9x
P/S RatioIs DVLA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DVLA income statement (TTM) | |
|---|---|
| Revenue | Rp2.13t |
| Cost of Revenue | Rp1.01t |
| Gross Profit | Rp1.12t |
| Other Expenses | Rp930.93b |
| Earnings | Rp193.91b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 173.13 |
| Gross Margin | 52.71% |
| Net Profit Margin | 9.09% |
| Debt/Equity Ratio | 0% |
How did DVLA perform over the long term?
See historical performance and comparisonDividends
6.6%
Current Dividend Yield62%
Payout RatioDoes DVLA pay a reliable dividends?
See DVLA dividend history and benchmarks| Darya-Varia Laboratoria dividend dates | |
|---|---|
| Ex Dividend Date | Nov 01 2024 |
| Dividend Pay Date | Nov 21 2024 |
| Days until Ex dividend | 21 days |
| Days until Dividend pay date | 1 day |
Does DVLA pay a reliable dividends?
See DVLA dividend history and benchmarks